Gastrointestinal Bleeding Treatment Market

Gastrointestinal Bleeding Treatment Market (Product: Endoscopic Hemostatic Devices, Closure Devices, and Others; and GI Tract Division: Upper GI Tract and Lower GI Tract) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Gastrointestinal Bleeding Treatment Market Outlook 2031

  • The industry was valued at US$ 518.3 Mn in 2022
  • It is estimated to grow at a CAGR of 5.4% from 2023 to 2031 and reach US$ 824.9 Mn by the end of 2031

Analyst Viewpoint

Excessive smoking and alcohol consumption and surge in demand for endoscopic hemostasis are fostering the gastrointestinal bleeding treatment market size.

Gastrointestinal bleeding requires early diagnosis and appropriate treatments to ensure patient well-being. Increase in adoption of minimally invasive surgeries is augmenting market expansion.

Technological advancements in medical devices are generating lucrative gastrointestinal bleeding treatment market opportunities for the organizations in this business.

Moreover, companies in global market are investing in new product launches and research and development activities to enhance their product portfolio and provide accurate and effective treatments to the patients.

Market Introduction

Gastrointestinal bleeding or gastrointestinal hemorrhage is bleeding that occurs within the gastrointestinal tract, which includes the organs involved in digestion from the mouth to the anus. Gastrointestinal (GI) bleeding can occur in various parts of the digestive system, including stomach, small intestine, esophagus, large intestine, and rectum.

Upper gastrointestinal bleeding and lower gastrointestinal bleeding are two major types of GI bleeding. The treatment for gastrointestinal bleeding depends on the underlying cause and severity of bleeding.

Fluid replacement, blood transfusion, endoscopic therapy, embolization, and surgery are some of the common treatments for gastrointestinal bleeding. Endoscopic hemostatic devices and closure devices are used for these treatments.

It is essential for individuals experiencing gastrointestinal bleeding to seek immediate medical attention to receive appropriate diagnosis and treatment.

Attribute Detail
Drivers
  • Excessive Smoking and Alcohol Consumption
  • Surge in Demand for Endoscopic Hemostasis

Excessive Smoking and Alcohol Consumption Fostering Gastrointestinal Bleeding Treatment Market Growth

Changing lifestyles and diets among the populations are leading to various diseases including gastrointestinal bleeding. Smoking increases the risk of developing gastrointestinal conditions, such as gastritis, gastroesophageal reflux disease (GERD), and peptic ulcers.

These conditions can cause irritation, inflammation, and damage to the lining of digestive tract. Excessive alcohol consumption can irritate and inflame the lining of stomach and esophagus, causing gastritis and esophagitis. Thus, excessive smoking and drinking habits are augmenting gastrointestinal bleeding treatment market development.

According to the World Health Organization (WHO), tobacco abuse and addiction lead to more than one million fatalities in India, which is one-sixth of the world deaths due to tobacco usage and accounts for 9.5% of all deaths in India.

Moreover, tobacco-related deaths will rise to a million, accounting for 10% of global deaths by 2030. Hence, increase in use of tobacco is fueling the gastrointestinal bleeding treatment market statistics.

Surge in Demand for Endoscopic Hemostasis Propelling Market Dynamics

Healthcare professionals prefer minimally invasive surgeries for various diseases as it has faster recovery time, fewer incisions, and less blood loss. Endoscopic hemostasis involves using an endoscope, a flexible tube with a camera, and light at its tip to visualize and treat bleeding lesions or blood vessels within the gastrointestinal tract.

Endoscopy enables direct visualization of the bleeding site, allowing physicians to accurately locate and assess the source of bleeding. Thus, surge in demand for endoscopic hemostasis is fostering the gastrointestinal bleeding treatment market value.

Technological advancements in surgical procedures allow surgeons to provide precise and effective treatments according to patient conditions and disease severity. Healthcare professionals use advanced equipment to ensure accuracy and efficiency. Thus, increase in investments in cutting-edge surgical devices is fueling the market progress.

Regional Outlook

Attribute Detail
Leading Region North America

As per the latest gastrointestinal bleeding treatment market analysis, North America dominated the global market in 2022. Increase in hospitalization rates and well-established healthcare infrastructure is likely to propel the market share during the forecast period.

Moreover, increase in consumption of alcohol among teenagers and young adults is driving the market progress.

According to the 2022 National Survey on Drug Use and Health (NSDUH), 221.3 million people ages 12 and older (78.5% in this age group) reported that they drank alcohol at some point in their lifetime, which registered approximately 5.7 million youth ages 12 to 17 (22.3% in this age group) consumed alcoholic drinks.

Analysis of Key Players in Gastrointestinal Bleeding Treatment Industry

As per the recent gastrointestinal bleeding treatment market trends, technological advancements in surgical procedures and developments in medical devices offer lucrative opportunities for companies in the industry.

Leading players in the market focus on future analysis of gastrointestinal bleeding treatment to provide appropriate solutions for the patients. Moreover, they are investing in research and development to introduce new medical devices and enhance their product portfolio.

Some of the players in the industry are Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Cook Group, Ovesco Endoscopy AG, Erbe Elektromedizin GmbH, STERIS, and US Medical Innovations.

These companies have been profiled in the gastrointestinal bleeding treatment market report based on various parameters including company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.

Key Developments

  • In September 2023, US Medical Innovations, a leading manufacturer of biomedical devices, launched new AI surgical system, Canady Robotic AI Surgical System. The new system offers AI-powered software programs and 3D navigational guided surgical planning.
  • In April 2023, Boston Scientific Corporation, a leading innovator of less invasive medical solutions, acquired Apollo Endosurgery, a publicly traded medical technology company, to advance gastrointestinal therapeutic endoscopy and endobariatrics. The company aims to provide a comprehensive suite of endoluminal surgery and endobariatric solutions to patients.

Gastrointestinal Bleeding Treatment Market Snapshot

Attribute Detail
Market Size in 2022 US$ 518.3 Mn
Market Forecast (Value) in 2031 US$ 824.9 Mn
Growth Rate (CAGR) 5.4%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Tons US$ Mn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy and recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Product
    • Endoscopic Hemostatic Devices
      • Thermal Devices
      • Mechanical Devices
    • Closure Devices
    • Others
  • GI Tract Division
    • Upper GI Tract
    • Lower GI Tract
  • End-user
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC countries
Companies Profiled
  • Boston Scientific Corporation
  • Olympus Corporation
  • CONMED Corporation
  • Cook Group
  • Ovesco Endoscopy AG
  • Erbe Elektromedizin GmbH
  • STERIS
  • US Medical Innovations
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global gastrointestinal bleeding treatment market in 2022?

It was valued at US$ 518.3 Mn in 2022

How is the gastrointestinal bleeding treatment sector expected to grow by 2031?

It is projected to register a CAGR of 5.4% from 2023 to 2031

What are the key factors driving the demand for gastrointestinal bleeding treatment?

Excessive smoking and alcohol consumption and surge in demand for endoscopic hemostasis

Which was the most lucrative region in the gastrointestinal bleeding treatment industry in 2022?

North America was the most lucrative region in 2022

Who are the prominent gastrointestinal bleeding treatment providers?

Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Cook Group, Ovesco Endoscopy AG, Erbe Elektromedizin GmbH, STERIS, and US Medical Innovations.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Gastrointestinal Bleeding Treatment Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution/Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast, 2017–2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Key Product/Brand Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast, by Product

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Product, 2017–2031

            6.3.1. Endoscopic Hemostatic Devices

                6.3.1.1. Thermal Devices

                6.3.1.2. Mechanical Devices

            6.3.2. Closure Devices

            6.3.3. Others

        6.4. Market Attractiveness Analysis, by Product

    7. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast, by GI Tract Division

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by GI Tract Division, 2017–2031

            7.3.1. Upper GI Tract

            7.3.2. Lower GI Tract

        7.4. Market Attractiveness Analysis, by GI Tract Division

    8. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by End-user, 2017–2031

            8.3.1. Hospitals

            8.3.2. Clinics

            8.3.3. Ambulatory Surgical Centers

            8.3.4. Others

        8.4. Market Attractiveness Analysis, by End-user

    9. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region, 2017–2031

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America Gastrointestinal Bleeding Treatment Market Analysis and Forecast

        10.1. Introduction

        10.2. Key Findings

        10.3. Market Value Forecast, by Product, 2017–2031

            10.3.1. Endoscopic Hemostatic Devices

                10.3.1.1. Thermal Devices

                10.3.1.2. Mechanical Devices

            10.3.2. Closure Devices

            10.3.3. Others

        10.4. Market Value Forecast, by GI Tract Division, 2017–2031

            10.4.1. Upper GI Tract

            10.4.2. Lower GI Tract

        10.5. Market Value Forecast, by End-user, 2017–2031

            10.5.1. Hospitals

            10.5.2. Clinics

            10.5.3. Ambulatory Surgical Centers

            10.5.4. Others

        10.6. Market Value Forecast, by Country, 2017–2031

            10.6.1. U.S.

            10.6.2. Canada

        10.7. Market Attractiveness Analysis

            10.7.1. By Product

            10.7.2. By GI Tract Division

            10.7.3. By End-user

            10.7.4. By Country

    11. Europe Gastrointestinal Bleeding Treatment Market Analysis and Forecast

        11.1. Introduction

        11.2. Key Findings

        11.3. Market Value Forecast, by Product, 2017–2031

            11.3.1. Endoscopic Hemostatic Devices

                11.3.1.1. Thermal Devices

                11.3.1.2. Mechanical Devices

            11.3.2. Closure Devices

            11.3.3. Others

        11.4. Market Value Forecast, by GI Tract Division, 2017–2031

            11.4.1. Upper GI Tract

            11.4.2. Lower GI Tract

        11.5. Market Value Forecast, by End-user, 2017–2031

            11.5.1. Hospitals

            11.5.2. Clinics

            11.5.3. Ambulatory Surgical Centers

            11.5.4. Others

        11.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.6.1. Germany

            11.6.2. U.K.

            11.6.3. France

            11.6.4. Italy

            11.6.5. Spain

            11.6.6. Rest of Europe

        11.7. Market Attractiveness Analysis

            11.7.1. By Product

            11.7.2. By GI Tract Division

            11.7.3. By End-user

            11.7.4. By Country/Sub-region

    12. Asia Pacific Gastrointestinal Bleeding Treatment Market Analysis and Forecast

        12.1. Introduction

        12.2. Key Findings

        12.3. Market Value Forecast, by Product, 2017–2031

            12.3.1. Endoscopic Hemostatic Devices

                12.3.1.1. Thermal Devices

                12.3.1.2. Mechanical Devices

            12.3.2. Closure Devices

            12.3.3. Others

        12.4. Market Value Forecast, by GI Tract Division, 2017–2031

            12.4.1. Upper GI Tract

            12.4.2. Lower GI Tract

        12.5. Market Value Forecast, by End-user, 2017–2031

            12.5.1. Hospitals

            12.5.2. Clinics

            12.5.3. Ambulatory Surgical Centers

            12.5.4. Others

        12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.6.1. China

            12.6.2. Japan

            12.6.3. India

            12.6.4. Australia & New Zealand

            12.6.5. Rest of Asia Pacific

        12.7. Market Attractiveness Analysis

            12.7.1. By Product

            12.7.2. By GI Tract Division

            12.7.3. By End-user

            12.7.4. By Country/Sub-region

    13. Latin America Gastrointestinal Bleeding Treatment Market Analysis and Forecast

        13.1. Introduction

        13.2. Key Findings

        13.3. Market Value Forecast, by Product, 2017–2031

            13.3.1. Endoscopic Hemostatic Devices

                13.3.1.1. Thermal Devices

                13.3.1.2. Mechanical Devices

            13.3.2. Closure Devices

            13.3.3. Others

        13.4. Market Value Forecast, by GI Tract Division, 2017–2031

            13.4.1. Upper GI Tract

            13.4.2. Lower GI Tract

        13.5. Market Value Forecast, by End-user, 2017–2031

            13.5.1. Hospitals

            13.5.2. Clinics

            13.5.3. Ambulatory Surgical Centers

            13.5.4. Others

        13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.6.1. Brazil

            13.6.2. Mexico

            13.6.3. Rest of Latin America

        13.7. Market Attractiveness Analysis

            13.7.1. By Product

            13.7.2. By GI Tract Division

            13.7.3. By End-user

            13.7.4. By Country/Sub-region

    14. Middle East & Africa Gastrointestinal Bleeding Treatment Market Analysis and Forecast

        14.1. Introduction

        14.2. Key Findings

        14.3. Market Value Forecast, by Product, 2017–2031

            14.3.1. Endoscopic Hemostatic Devices

                14.3.1.1. Thermal Devices

                14.3.1.2. Mechanical Devices

            14.3.2. Closure Devices

            14.3.3. Others

        14.4. Market Value Forecast, by GI Tract Division, 2017–2031

            14.4.1. Upper GI Tract

            14.4.2. Lower GI Tract

        14.5. Market Value Forecast, by End-user, 2017–2031

            14.5.1. Hospitals

            14.5.2. Clinics

            14.5.3. Ambulatory Surgical Centers

            14.5.4. Others

        14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.6.1. GCC Countries

            14.6.2. South Africa

            14.6.3. Rest of Middle East & Africa

        14.7. Market Attractiveness Analysis

            14.7.1. By Product

            14.7.2. By GI Tract Division

            14.7.3. By End-user

            14.7.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

        15.2. Market Share Analysis, by Company (2022)

        15.3. Company Profiles

            15.3.1. Boston Scientific Corporation

                15.3.1.1. Company Overview

                15.3.1.2. Product Portfolio

                15.3.1.3. SWOT Analysis

                15.3.1.4. Financial Overview

                15.3.1.5. Strategic Overview

            15.3.2. Olympus Corporation

                15.3.2.1. Company Overview

                15.3.2.2. Product Portfolio

                15.3.2.3. SWOT Analysis

                15.3.2.4. Financial Overview

                15.3.2.5. Strategic Overview

            15.3.3. CONMED Corporation

                15.3.3.1. Company Overview

                15.3.3.2. Product Portfolio

                15.3.3.3. SWOT Analysis

                15.3.3.4. Financial Overview

                15.3.3.5. Strategic Overview

            15.3.4. Cook Group

                15.3.4.1. Company Overview

                15.3.4.2. Product Portfolio

                15.3.4.3. SWOT Analysis

                15.3.4.4. Financial Overview

                15.3.4.5. Strategic Overview

            15.3.5. Ovesco Endoscopy AG

                15.3.5.1. Company Overview

                15.3.5.2. Product Portfolio

                15.3.5.3. SWOT Analysis

                15.3.5.4. Financial Overview

                15.3.5.5. Strategic Overview

            15.3.6. Erbe Elektromedizin GmbH

                15.3.6.1. Company Overview

                15.3.6.2. Product Portfolio

                15.3.6.3. SWOT Analysis

                15.3.6.4. Financial Overview

                15.3.6.5. Strategic Overview

            15.3.7. STERIS

                15.3.7.1. Company Overview

                15.3.7.2. Product Portfolio

                15.3.7.3. SWOT Analysis

                15.3.7.4. Financial Overview

                15.3.7.5. Strategic Overview

            15.3.8. US Medical Innovations

                15.3.8.1. Company Overview

                15.3.8.2. Product Portfolio

                15.3.8.3. SWOT Analysis

                15.3.8.4. Financial Overview

                15.3.8.5. Strategic Overview

    List of Tables

    Table 01: Global Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Product, 2017–2031

    Table 02: Global Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by GI Tract Division, 2017–2031

    Table 03: Global Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 04: Global Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Region, 2017–2031

    Table 05: North America Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2031

    Table 06: North America Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Product, 2017–2031

    Table 07: North America Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by GI Tract Division, 2017–2031

    Table 08: North America Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 09: Europe Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 10: Europe Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Product, 2017–2031

    Table 11: Europe Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by GI Tract Division, 2017–2031

    Table 12: Europe Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 13: Asia Pacific Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Asia Pacific Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Product, 2017–2031

    Table 15: Asia Pacific Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by GI Tract Division, 2017–2031

    Table 16: Asia Pacific Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 17: Latin America Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 18: Latin America Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Product, 2017–2031

    Table 19: Latin America Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by GI Tract Division, 2017–2031

    Table 20: Latin America Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 21: Middle East & Africa Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Middle East & Africa Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Product, 2017–2031

    Table 23: Middle East & Africa Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by GI Tract Division, 2017–2031

    Table 24: Middle East & Africa Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figures

    Figure 01: Global Gastrointestinal Bleeding Treatment Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031

    Figure 02: Global Gastrointestinal Bleeding Treatment Market Revenue (US$ Mn), by Product, 2022

    Figure 03: Global Gastrointestinal Bleeding Treatment Market Value Share, by Product, 2022

    Figure 04: Global Gastrointestinal Bleeding Treatment Market Revenue (US$ Mn), by GI Tract Division, 2022

    Figure 05: Global Gastrointestinal Bleeding Treatment Market Value Share, by GI Tract Division, 2022

    Figure 06: Global Gastrointestinal Bleeding Treatment Market Revenue (US$ Mn), by End-user, 2022

    Figure 07: Global Gastrointestinal Bleeding Treatment Market Value Share, by End-user, 2022

    Figure 08: Global Gastrointestinal Bleeding Treatment Market Value Share, by Region, 2022

    Figure 09: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, 2017–2031

    Figure 10: Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2022–2031

    Figure 11: Global Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Product, 2023-2031

    Figure 12: Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2022–2031

    Figure 13: Global Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by GI Tract Division, 2023-2031

    Figure 14: Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2022–2031

    Figure 15: Global Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by End-user, 2022-2031

    Figure 16: Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Region, 2022–2031

    Figure 17: Global Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Region, 2022-2031

    Figure 18: North America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 19: North America Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country, 2023–2031

    Figure 20: North America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country, 2022–2031

    Figure 21: North America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2022–2031

    Figure 22: North America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2022–2031

    Figure 23: North America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2022–2031

    Figure 24: North America Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Product, 2023–2031

    Figure 25: North America Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by GI Tract Division, 2023–2031

    Figure 26: North America Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 27: Europe Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 28: Europe Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 29: Europe Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 30: Europe Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2022–2031

    Figure 31: Europe Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2022–2031

    Figure 32: Europe Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2022–2031

    Figure 33: Europe Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Product, 2023–2031

    Figure 34: Europe Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by GI Tract Division, 2023–2031

    Figure 35: Europe Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 36: Asia Pacific Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 37: Asia Pacific Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 38: Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 39: Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2022–2031

    Figure 40: Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2022–2031

    Figure 41: Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2022–2031

    Figure 42: Asia Pacific Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Product, 2023–2031

    Figure 43: Asia Pacific Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by GI Tract Division, 2023–2031

    Figure 44: Asia Pacific Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 45: Latin America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 46: Latin America Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 47: Latin America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 48: Latin America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2022–2031

    Figure 49: Latin America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2022–2031

    Figure 50: Latin America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2022–2031

    Figure 51: Latin America Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Product, 2023–2031

    Figure 52: Latin America Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by GI Tract Division, 2023–2031

    Figure 53: Latin America Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 54: Middle East & Africa Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 55: Middle East & Africa Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 56: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 57: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2022–2031

    Figure 58: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2022–2031

    Figure 59: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2022–2031

    Figure 60: Middle East & Africa Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Product, 2023–2031

    Figure 61: Middle East & Africa Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by GI Tract Division, 2023–2031

    Figure 62: Middle East & Africa Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by End-user, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved